ATA Action's Letter to the DEA Re: Telemedicine Prescribing of Controlled Substances When the Practitioner and the Patient Have Not Had a Prior In-Person Medical Evaluation

ATA Action submitted comments regarding the Drug Enforcement Administration (DEA)’s proposed rules regarding telemedicine prescribing of controlled substances when the practitioner and the patient have not had a prior in-person medical evaluation.